Unveiling the Link between Prostatitis and Periodontitis

Background: One of the important tumor markers having critically important applications in every aspect of treating men with prostatic illness is prostate-specific antigen (PSA), formed by prostate acini's epithelial cells. Where prostate is affected by inflammation or malignancy, the PSA levels rise to/and above 4 ng/ml. This study analyzes the interlink between different severity of periodontitis and prostatitis by assessment of PSA antigen levels and periodontal clinical parameters. Materials and Methods: In this study, 100 chronic prostatitis patients diagnosed to also have periodontal diseases were divided into four batches on the basis of the nature of prostatitis and levels of periodontal clinical attachment. The grouping was as: group 1A – clinical attachment level (CAL) <3 mm and mild prostatitis, Group 2A – CAL ≥3 mm and mild prostatitis, and Group 1B – CAL <3 mm and moderate-to-severe prostatitis, Group 2B – CAL ≥3 mm and moderate-to-severe prostatitis. Readings of CAL, probing pocket depth, bleeding on probing, plaque index, and gingival index (PI and GI) were recorded, followed by calculation and assessment of PSA values and correlation of periodontal parameters, respectively. Results: An important and affirmative correlation (r = 0.5549, P < 0.05) was seen between PSA and CAL scores at significance level of 5%, and also between PSA and probing depths (PD) scores at 5% (r = 0.5315, P < 0.05), indicating that PSA and CAL scores, as also PSA and PD scores are mutually dependent. The similar positive correlation was seen between PSA with PI (r = 0.3231, P < 0.05) and GI (r = 0.3567, P < 0.05) scores, respectively, at 5% level of significance, which shows PSA is also mutually dependent on PI and GI scores. Conclusion: Patients with of grades, moderate-to-severe prostatitis as well as periodontitis were found having higher PSA levels. The clinical readings of periodontal parameters were significantly higher in patients with moderate-to-severe prostatitis which shows a pathological link between the above two.

[1]  Young-Taek Kim,et al.  Association between Periodontal disease and Prostate cancer: Results of a 12-year Longitudinal Cohort Study in South Korea , 2017, Journal of Cancer.

[2]  G. MacLennan,et al.  Periodontal Treatment Improves Prostate Symptoms and Lowers Serum PSA in Men with High PSA and Chronic Periodontitis , 2015 .

[3]  K. Park,et al.  Optimal Baseline Prostate-Specific Antigen Level to Distinguish Risk of Prostate Cancer in Healthy Men Between 40 and 69 Years of Age , 2011, Journal of Korean medical science.

[4]  K. Park,et al.  Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL? , 2011, World Journal of Urology.

[5]  G. MacLennan,et al.  Association between periodontal disease and prostate-specific antigen levels in chronic prostatitis patients. , 2010, Journal of periodontology.

[6]  A. Metin,et al.  Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. , 2007, Urology.

[7]  C. Amling Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening? , 2006, Current treatment options in oncology.

[8]  A. Jl Diagnosis of Periodontal Diseases. , 2004, Journal of periodontology.

[9]  A. Schaeffer,et al.  The role of cytokines in prostatitis , 2003, World Journal of Urology.

[10]  M. Trevisan,et al.  Periodontal infections contribute to elevated systemic C-reactive protein level. , 2001, Journal of periodontology.

[11]  J. Morote,et al.  Effect of Inflammation and Benign Prostatic Enlargement on Total and Percent Free Serum Prostatic Specific Antigen , 2000, European Urology.

[12]  W. Catalona,et al.  The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels. , 1999, The Journal of urology.

[13]  H. Yildirim,et al.  Destructive membranous periodontal disease (Ligneous periodontitis). , 1999, Journal of periodontology.

[14]  E. Diamandis Prostate specific antigen--new applications in breast and other cancers. , 1996, Anticancer research.

[15]  P. Humphrey,et al.  Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. , 1995, The Journal of urology.

[16]  Y. Asada,et al.  Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia , 1994, The Prostate.

[17]  R. Thin The diagnosis of prostatitis: a review. , 1991, Genitourinary medicine.